GlassScriptPhysician profile
Elizabeth A Riddle
NPI 1720075633
$1,521.00
in general payments reported to CMS, 2019-2025
15 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $94.47 · 2022: $744 · 2023: $376 · 2024: $131 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $682.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,102.71 | 2022-2025 | Wavewriter Alpha Prime 16, Sterling, Freelink |
| Hikma Pharmaceuticals USA | $53.80 | 2022 | |
| Tersera Therapeutics LLC | $51.31 | 2023-2024 | Prialt |
| Pacira Pharmaceuticals Incorporated | $50.27 | 2023-2024 | Iovera, Zilretta |
| Collegium Pharmaceutical, INC. | $44.47 | 2022-2024 | Belbuca |
| Biotissue Holdings INC. | $42.14 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $22.81 | 2024 | |
| Scilex Pharmaceuticals INC. | $21.87 | 2021 | |
| Welch Allyn | $21.60 | 2021 | |
| Reprise Biomedical, INC. | $21.44 | 2025 | Miro 3d |
| Bayer Healthcare Pharmaceuticals INC. | $19.51 | 2023 | |
| Medtronic, INC. | $18.94 | 2021 | |
| Biodelivery Sciences International, INC. | $18.13 | 2021 | |
| Spinal Simplicity, LLC | $18.07 | 2024 | Ha Minuteman G3-R |
| Redhill Biopharma INC. | $13.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Riddle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.